Akebia Therapeutics (AKBA)
(Delayed Data from NSDQ)
$1.37 USD
0.00 (0.00%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.40 +0.03 (2.19%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.05 | 0.00% |
Earnings Summary
For their last quarter, Akebia Therapeutics (AKBA) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 33.33%. Look out for AKBA's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.05 per share, reflecting a year-over-year increase of 37.5%.
Earnings History
Price & Consensus
Zacks News for AKBA
Here's Why You Should Consider Buying Akebia (AKBA) Stock
AKBA: What are Zacks experts saying now?
Zacks Private Portfolio Services